Phase 2 Type 2 Diabetes Trial, Recruiting NCT07374328 Sponsor: Second Affiliated Hospital of Guangzhou Medical University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 2 Type 2 Diabetes Trial, Recruiting

NCT07374328
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have recently been diagnosed with type 2 diabetes.
  • People aged between 18 and 65 years old.
  • People whose HbA1c (a blood test that measures average blood sugar levels over the past few months) is 9.0% or higher.

Who may not be able to join:

  • People who have type 1 diabetes.
  • People with elevated levels of creatinine (a marker of kidney function) or a high albumin-to-creatinine ratio in their urine (a sign of kidney stress) — confirm with trial site if unsure which specific levels apply.
  • People who also have coronary heart disease (a condition affecting the heart's blood supply), any type of cancer, or who are pregnant.
  • People who are currently taking glucocorticoids (a type of steroid medication often used to reduce inflammation).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 86-20-34152032

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Second Affiliated Hospital of Guangzhou Medical University
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
31 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diabetes remission rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov